Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells. (Q47313068)

13 January 2018

title

Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells. (English)

1 reference

13 January 2018

1 reference

Bo Ma

1

1 reference

13 January 2018

Hanfang Jiang

2

1 reference

13 January 2018

Jun Jia

3

1 reference

13 January 2018

Lijun Di

4

1 reference

13 January 2018

Guohong Song

5

1 reference

13 January 2018

Jing Yu

6

1 reference

13 January 2018

Yulin Zhu

7

1 reference

13 January 2018

Zhihao Lu

8

1 reference

13 January 2018

Xiaoli Wang

9

1 reference

13 January 2018

Xinna Zhou

10

1 reference

13 January 2018

Jun Ren

11

1 reference

13 January 2018

publication date

27 July 2012

1 reference

13 January 2018

Clinical and Translational Oncology

published in

1 reference

13 January 2018

volume

14

1 reference

13 January 2018

issue

10

1 reference

13 January 2018

page(s)

764-773

1 reference

13 January 2018

https://scigraph.springernature.com/pub.10.1007/s12094-012-0860-9

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Major causes of death among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Liver transplantation: an update 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

New therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Bone marrow stromal stem cells: nature, biology, and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Mesenchymal stem cell: use and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Human mesenchymal stem cells signals regulate neural stem cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

B lymphocytes secrete antigen-presenting vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Tumor-derived exosomes: a new source of tumor rejection antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Production and characterization of clinical grade exosomes derived from dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Malignant effusions and immunogenic tumour-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Molecular chaperones and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Platelet-derived growth factor signaling and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Cytotoxicity of rat marrow stromal cells against malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Hepatocellular carcinoma: current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0860-9

Hepatocellular carcinoma: therapy and prevention

21 January 2018

1 reference

12 December 2020

Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules

1 reference

12 December 2020

Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)

1 reference

12 December 2020

Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor

1 reference

12 December 2020

Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors

1 reference

12 December 2020

Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization

1 reference

12 December 2020

Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo

1 reference

12 December 2020

Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells

1 reference

12 December 2020

Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell

1 reference

12 December 2020

Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70

1 reference

12 December 2020

Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro

1 reference

12 December 2020

Cancer vaccines: finding the best way to train the immune system

1 reference

12 December 2020

The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer

1 reference

12 December 2020

Plasticity of marrow-derived stem cells

1 reference

12 December 2020

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

1 reference

12 December 2020

[Inoculation of murine bone marrow mesenchymal stem cells induces tumor necrosis in mouse with orthotopic hepatocellular carcinoma].

1 reference

12 December 2020

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

1 reference

12 December 2020

10.1007/S12094-012-0860-9

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

22855153

1 reference

13 January 2018